Climb Bio, Inc. (CLYM) Misses Q4 EPS by 7c

Climb Bio, Inc. (NASDAQ: CLYM) reported Q4 EPS of ($0.26), $0.07 worse than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Market Vectors Semiconductor ETF (SMH) call put ratio 1 call to 1.7 puts as share price up 1%
• Western Digital (WDC) call put ratio 1 call to 1.2 puts on 57K contracts